STO advances global oncology and patient care by bridging scientific discovery and clinical application, promoting equitable healthcare, and harmonizing cancer.
It's #NationalCancerSurvivorsDay. Join us in celebrating the millions of people in the United States and worldwide who are living with, through, and beyond a cancer diagnosis thanks to lifesaving research. brnw.ch/21x39Pn
Today we honor cancer survivors around the world.
Survivorship is not just about surviving cancer. It is about having the support, follow-up care, and resources needed to live well beyond it.
#NationalCancerSurvivorsDay#CancerSurvivorship
Today is Clinical Trials Day. At STO, we recognize the value of clinical research and the need for trials that are accessible, inclusive, and relevant to real-world patients. #ClinicalTrialsDay#ResearchRising#CTD2026#STO
Political will and government commitment are essential to tackle Africa’s growing cancer burden - through national policies, dedicated funding, expanded screening, a trained workforce and improved treatment access.
Read more: buff.ly/iIORPUW#CancerCare#Africa
Twitter / X
“Progress depends not only on clinical capacity, but also on political will.”
In a new STO expert perspective, @roseanorlu examines the role of government commitment in scaling equitable cancer care across Africa.
buff.ly/jyI7Tgj#GlobalHealth#CervicalCancer
Who Can Benefit From a Cancer Genetic Evaluation? Considerations for Genetic Risk Evaluation and Testing Based on Tumor Type and Pathology | JCO Oncology Advances buff.ly/ntOQMN7
New paper in @NatRevClinOncol !
We propose “time budgeting” as a new design principle for cancer care: treating patient time as a finite resource that should be measured, protected, and incorporated into care pathways & clinical trials.
Because time is also a toxicity. ⏳
Cervical cancer screening fails when results require return visits. The fix: connected systems. STO's World Health Day blog on HPV testing, AI triage, and point-of-care innovations that close the follow-up gap. buff.ly/vqsPBgY